Suchergebnisse - "Ragnarsson, Oskar"

  1. 1
  2. 2
  3. 3
  4. 4

    Dateibeschreibung: application/pdf

    Relation: The authors thank Svetlana Popova from the research unit (FoU) at Uppsala University Hospital for her assistance in preparing the specimens for DNA extraction. The authors also appreciate the help of Elisabet Englund and Inga Gudinaviciene from the Department of Pathology at Lund University Hospital, as well as Stine Horsk\u00E6r Madsen from the University Hospital in Aarhus, Denmark, for their help in collecting the specimens. Special thanks to the PCR and FISH laboratories in Odense for their excellent technical assistance. The authors are grateful to the biobanks at the participating hospitals for collaboration on the collection of the tissue specimens. Henning Boldt presented the preliminary results of this study at the European Society of Endocrinology Congress held in Stockholm, May 2024. This study has received financial support from Pfizer AB (GRG number 70598835), Recordati AB, the Swedish Medical Society (Svenska L\u00E4kars\u00E4llskapet; grant SLS-961569), Lions Cancerforskningsfond, and U-CAN. The collection of tissue material from patients who underwent surgery at the Uppsala University Hospital was supported by U-CAN, through Uppsala Biobank and the Department of Clinical Pathology, Uppsala University Hospital. OC-B has received Gullstrandstj\u00E4nst 2023-2027 and a grant from the Swedish state under the agreement between the Swedish government and the county councils (ALF). JJ has received a grant from the Swedish state under the same agreement between the Swedish government and the county councils (ALF) and from the Region Uppsala research funds. UF-R\u2019s research salary was sponsored by a grant from Kirsten and Freddy Johansen\u2019s Fund. CS-J received funding from the Helsinki University Hospital Research Funds (TYH2018223) and Finska L\u00E4kares\u00E4llskapet. The funding bodies had no role in the design of the study; collection, analysis, or interpretation of the data; or in the writing of the manuscript.; http://hdl.handle.net/10138/588701; 85209875877; 001376851700001

  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Quelle: Pharmacoepidemiology & Drug Safety; Oct2023 Supplement 1, Vol. 32, p643-675, 33p

  18. 18

    Weitere Verfasser: Arlien-Søborg, Mai C. Dal, Jakob Heck, Ansgar et al.

    Dateibeschreibung: application/pdf

    Relation: Jens Otto Lunde J\u00F8rgensen and Jakob Dal have received unrestricted research grants and lecture fees from Pfizer and IPSEN. Mai C. Arlien\u2010S\u00F8borg has received lecture fees from Pfizer. Daniel Olsson has served as a consultant for Ipsen, Pfizer, Novo Nordisk, and Sandoz; has received research grants from Sandoz and Pfizer; and is an employee at AstraZeneca as of 30 August 2021. This work was supported by an unrestricted research grant from Pfizer. The other authors declare no conflict of interest.; http://hdl.handle.net/10138/585324; 85195918201; 001244261400001

  19. 19
  20. 20